Vicente Aleixandre Benites-Zapata

Dr. Vicente Aleixandre Benites-Zapata


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Fertility and Sterility
Verified
Journal Article
Closed access
FPFaustino R. Pérez-López
Faustino R. Pérez-López
VPVinay Pasupuleti
Vinay Pasupuleti
EMEdward Mezones-Holguin
Edward Mezones-Holguin
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata
PTPriyaleela Thota
Priyaleela Thota
Adrian V. HernandezAdrian V. Hernandez
Adrian V. Hernandez

1 December 2015 in European Journal of Cancer
Verified
Journal Article
Open access
Adrian V. HernandezAdrian V. Hernandez
Adrian V. Hernandez
VPVinay Pasupuleti
Vinay Pasupuleti
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata
PTPriyaleela Thota
Priyaleela Thota
ADAbhishek Deshpande
Abhishek Deshpande
FPFaustino R. Perez-Lopez
Faustino R. Perez-Lopez
It has been suggested that chronic hyperinsulinemia from insulin resistance is involved in the etiology of endometrial cancer (EC). We performed a systematic review and meta-analysis to assess whether insulin resistance is associated with the risk of EC. We searched PubMed-Medline, Embase, Scopus, and Web of Science for articles published from database inception through 30th September 2014. We included all observational studies evaluating components defining insulin resistance in women with and without EC. Quality of the included studies was assessed by Newcastle-Ottawa scale. Random-effects models and inverse variance method were used to meta-analyze the association between insulin resistance components and EC. Twenty-five studies satisfied our inclusion criteria. Fasting insulin levels (13 studies, n = 4088) were higher in women with EC (mean difference [MD] 33.94 pmol/L, 95% confidence interval [CI] 15.04-52.85, p = 0.0004). No differences were seen in postmenopausal versus pre- and postmenopausal subgroup analysis. Similarly, non-fasting/fasting C-peptide levels (five studies, n = 1938) were also higher in women with EC (MD 0.14 nmol/L, 95% CI 0.08-0.21, p < 0.00001). Homeostatic model assessment - insulin resistance (HOMA-IR) values (six studies, n = 1859) in EC patients were significantly higher than in women without EC (MD 1.13, 95% CI 0.20-2.06, p = 0.02). There was moderate-to-high heterogeneity among the included studies. Currently available epidemiologic evidence is suggestive of significantly higher risk of EC in women with high fasting insulin, non-fasting/fasting C-peptide and HOMA-IR values.

1 May 2021 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
DUDiego Urrunaga-Pastor
Diego Urrunaga-Pastor
Guido Bendezu-QuispeGuido Bendezu-Quispe
Guido Bendezu-Quispe
PHPercy Herrera-Añazco
Percy Herrera-Añazco
Angela UyenAngela Uyen
Angela Uyen
CTCarlos J. Toro-Huamanchumo
Carlos J. Toro-Huamanchumo
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata

1 January 2015 in The American Journal of Cardiology
Verified
Journal Article
Closed access
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata
Adrian V. HernandezAdrian V. Hernandez
Adrian V. Hernandez
VNVijaiganesh Nagarajan
Vijaiganesh Nagarajan
CCClay A. Cauthen
Clay A. Cauthen
RSRandall C. Starling
Randall C. Starling
WTW.H. Wilson Tang
W.H. Wilson Tang

31 January 2023 in Healthcare Informatics Research
Verified
Journal Article
Open access
PDF file
KTKimberly G. Tuco
Kimberly G. Tuco
SCSharong D. Castro-Diaz
Sharong D. Castro-Diaz
DSDavid R. Soriano-Moreno
David R. Soriano-Moreno
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata
Objectives: The aim of this study was to assess the prevalence of nomophobia in university students.Methods: A systematic search was conducted of the following databases: Web of Science/ Core Collection, Scopus, PubMed, Embase, and Ovid/ MEDLINE until March 2021. Cross-sectional studies reporting the prevalence of nomophobia in undergraduate or postgraduate university students that assessed nomophobia with the 20-item Nomophobia Questionnaire (NMP-Q) tool were included. Study selection, data extraction, and risk of bias assessment were performed in duplicate. A meta-analysis of proportions was performed using a random-effects model. Heterogeneity was assessed using sensitivity analysis according to the risk of bias, and subgrouping by country, sex, and major.Results: We included 28 cross-sectional studies with a total of 11,300 participants from eight countries, of which 23 were included in the meta-analysis. The prevalence of mild nomophobia was 24% (95% confidence interval [CI], 20%–28%; I2 = 95.3%), that of moderate nomophobia was 56% (95% CI, 53%–60%; I2 = 91.2%), and that of severe nomophobia was 17% (95% CI, 15%–20%; I2 = 91.7%). Regarding countries, Indonesia had the highest prevalence of severe nomophobia (71%) and Germany had the lowest (3%). The prevalence was similar according to sex and major.Conclusions: We found a high prevalence of moderate and severe nomophobia in university students. Interventions are needed to prevent and treat this problem in educational institutions.

28 June 2016 in HIV Medicine
Verified
Journal Article
Closed access
PDF file
Adrian V. HernandezAdrian V. Hernandez
Adrian V. Hernandez
PTP Thota
P Thota
DPD Pellegrino
D Pellegrino
VPV Pasupuleti
V Pasupuleti
VBVicente Aleixandre Benites-Zapata
Vicente Aleixandre Benites-Zapata
JVJe Vidal
Je Vidal